These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6019731)

  • 1. Urocanic acid in benign and malignant human epidermal tumors.
    Baden HP; Mittler B; Sviokla S; Pathak MA
    J Natl Cancer Inst; 1967 Feb; 38(2):205-8. PubMed ID: 6019731
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
    J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of keratinisation.
    Stollery N
    Practitioner; 2007 Sep; 251(1698):60-5. PubMed ID: 17955881
    [No Abstract]   [Full Text] [Related]  

  • 4. Tryptophan-niacin pathway in the human epidermis.
    Calandra P
    Acta Vitaminol Enzymol; 1974; 28(5):189-94. PubMed ID: 4480340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histochemical studies of the lipid contents in some tumors of the skin].
    Balabanow K; Dimitrowa J
    Arch Klin Exp Dermatol; 1970; 236(4):428-32. PubMed ID: 5442140
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carcinoma and keratoacanthoma but not in basal cell carcinoma of the skin.
    Vahlquist A; Andersson E; Coble BI; Rollman O; Törmä H
    J Invest Dermatol; 1996 May; 106(5):1070-4. PubMed ID: 8618041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the 27-kDa heat shock protein in human epidermis and in epidermal neoplasms: an immunohistological study.
    Trautinger F; Kindas-Mügge I; Dekrout B; Knobler RM; Metze D
    Br J Dermatol; 1995 Aug; 133(2):194-202. PubMed ID: 7547384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases.
    Tomková H; Fujimoto W; Arata J
    Br J Dermatol; 1997 Nov; 137(5):703-8. PubMed ID: 9415228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on the accumulation of prophyrin metabolites (endogenous?) in epithelial tumors of the skin].
    Amerio PL; Bossi G; Rusciani L
    G Ital Dermatol Minerva Dermatol; 1970 Feb; 45(2):65-7. PubMed ID: 5467615
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract]   [Full Text] [Related]  

  • 14. Keratin 17 expression as a marker for epithelial transformation in viral warts.
    Proby CM; Churchill L; Purkis PE; Glover MT; Sexton CJ; Leigh IM
    Am J Pathol; 1993 Dec; 143(6):1667-78. PubMed ID: 7504888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma.
    Klein-Szanto AJ; Barr RJ; Reiners JJ; Mamrack MD
    Arch Pathol Lab Med; 1984 Nov; 108(11):888-90. PubMed ID: 6385922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
    Fernandez-Flores A
    Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
    [No Abstract]   [Full Text] [Related]  

  • 20. [Expression of various keratins in basal cell, metastatic, and squamous cell skin cancer].
    Kazantseva IA; Khlebnikova AN; Babaev VR
    Biull Eksp Biol Med; 1994 Sep; 118(9):300-3. PubMed ID: 7529596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.